2013China Medicine and PharmacyRequires access

Effectiveness and safety of simvastatin in the treatment of coronary heart disease in patients with dyslipidemia

Yu Pen

Open publisher page 0 citations

Abstract

Objective To evaluate the effectiveness and safety of different dose of simvastatin in the treatment of coronary heart disease in patients with dyslipidemia.Methods Totol 86 patients with definite diagnosis of coronary heart disease were divided into two groups,43 patients in each group.The low dose group were treated with 20 mg simvastatin and high dose group with 40 mg simvastatin once each night.Analyzed the changes of lipids and the untoward reactions in two groups.Results The blood lipids were decreased significantly after 12 weeks treatment(P 0.05),and the lipid improvement in hign dose group was better than in low dose group(P 0.01).Conclusion Simvastatin could significantly improve the blood lipids and is relatively reliable in treatment of coronary heart disease.

About this research paper

What this paper is about

Objective To evaluate the effectiveness and safety of different dose of simvastatin in the treatment of coronary heart disease in patients with dyslipidemia.Methods Totol 86 patients with definite diagnosis of coronary heart disease were divided into two groups,43 patients in each group.The low dose group were treated with 20 mg simvastatin and high dose group with 40 mg simvastatin once each night.Analyzed the changes of lipids and the untoward reactions in two groups.Results The blood lipids were decreased significantly after 12 weeks treatment(P 0.05),and the lipid improvement in hign dose group was better than in low dose group(P 0.01).Conclusion Simvastatin could significantly improve the blood lipids and is relatively reliable in treatment of coronary heart disease.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the effectiveness and safety of different dose of simvastatin in the treatment of coronary heart disease in patients with dyslipidemia.Methods Totol 86 patients with definite diagnosis of coronary heart disease were divided into two groups,43 patients in each group.The low dose group were treated with 20 mg simvastatin and high dose group with 40 mg simvastatin once each night.Analyzed the changes of lipids and the untoward reactions in two groups.Results The blood lipids were decreased significantly after 12 weeks treatment(P 0.05),and the lipid improvement in hign dose group was better than in low dose group(P 0.01).Conclusion Simvastatin could significantly improve the blood lipids and is relatively reliable in treatment of coronary heart disease.

Key concepts: Simvastatin, Medicine, Dyslipidemia, Coronary heart disease, Blood lipids, Internal medicine, Cardiology, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Effectiveness and safety of simvastatin in the treatment of coronary heart disease in patients with dyslipidemia — Research Paper | ScholarLens